REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

THIRD QUARTER TRADING UPDATE

20 Oct 2005 06:00

EMBARGOED RELEASE 07:00 HOURS 20 October 2005 SOPHEON PLC THIRD QUARTER TRADING UPDATE In accordance with the requirements of Euronext Amsterdam, Sopheon plc("Sopheon") issues its trading update for the third quarter of 2005. The thirdquarter is traditionally quiet in the software industry, but the value ofSopheon's new sales orders taken during the quarter significantly exceeded theequivalent period in 2004, and was broadly equal to the total new salesachieved in the first six months of 2005. During the third quarter, includingextensions, Sopheon signed eight license sales and four proof of conceptengagements, in addition to several incremental consulting assignments fromexisting clients.In our results statement for the six months to 30 June 2005, we identifiedseven license opportunities as larger and more complex than the historicaverage. Of these, two have now concluded in a license order (included in thetotal count of eight for the quarter) and four are engaged in proof of conceptactivities. One of these has already contracted for its license, subject to anacceptance decision in the fourth quarter. The seventh opportunity remains incontract negotiations; this is also one of three opportunities carried forwardfrom the second quarter, of which the other two have concluded in a licenseorder.The volume of service revenues continues to show momentum in conjunction withlicense sales and proof of concept activity. As indicated in our interimstatement, we have continued to develop our partnerships to expand ourimplementation capacity and to act as a source of introductions to potentialnew customers. During the period we formed relationships with three leadingconsultancies in product development, each with an international footprint.Further details will be announced in due course. In addition, to support bothcurrent needs and anticipated growth, we have recruited a senior IT executiveto lead service delivery in Europe. Amit Eitan has 26 years experience inleading international IT organizations, and will be based in our offices inMaastricht.Initial findings from our research into the application of our EuropeanAccolade-based healthcare solution into the US market have been positive. Weare now considering how best to achieve progress in this area withoutdisrupting activities in our core vertical markets.The recent sales have led to good revenue growth over the first and secondquarters of 2005, however a proportion of the revenues deriving from these newsales will not be booked until next year. Nevertheless, Sopheon hasdemonstrated renewed commercial progress in the third quarter, and at the dateof this report, visibility of 2005 revenues stands at ‚£4.1 million, which is95% of the revenues recorded in 2004. Visibility includes new orders, recurringmaintenance streams, and contracted license revenues conditional on acceptancedecisions. It does not include potential license sales to other customers underproof of concept, which along with several other new license opportunities, arebeing closely pursued for closure before year end. Our reported performanceremains sensitive to the timing, value and profile of individual sales events.However the fourth quarter is typically a busy one for software businesses andthis was certainly true for Sopheon in 2004. Our sales teams are focused onactive pipelines with substantial sales potential, and are working hard toclose out the final months of 2005 with strong momentum.Sopheon's Chairman, Barry Mence said:"Sopheon's third quarter sales performance has been higher than the seasonalnorm and this return to growth, together with our pipeline of potentialbusiness for the final quarter of 2005, gives us confidence that we will have astrong finish to the current year."For further information contact:Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Andrew Tan Hansard Communications Tel : + 44 (0) 207 245 1100 + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010About SopheonSopheon (LSE: SPE) is an international provider of software and services thathelp organizations improve the business impact of innovation. The SopheonAccolade‚® product portfolio and process management system automates gate- orphase-based product development (PD) processes and provides strategic decisionsupport that allows companies to cut product development spending waste andgenerate more revenue from new products. Sopheon is listed on the AIM market ofthe London Stock Exchange and on the Euronext in the Netherlands. For moreinformation, please visit www.sopheon.com.ENDSOPHEON PLC
Date   Source Headline
21st Feb 20247:00 amRNSCancellation - Sopheon Plc
20th Feb 20244:31 pmRNSScheme of Arrangement becomes Effective
20th Feb 20247:30 amRNSSuspension - Sopheon plc
16th Feb 20241:40 pmRNSIssue of Equity, PDMR Dealing and Rule 2.9
16th Feb 20241:35 pmRNSCourt Sanction of Scheme of Arrangement
16th Feb 20249:04 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
14th Feb 20248:32 amRNSForm 8.5 (EPT/NON-RI)
13th Feb 20245:30 pmRNSSopheon
9th Feb 20243:30 pmRNSForm 8.3 - SPHN LN
9th Feb 20249:35 amRNSForm 8.3 - Sopheon plc
9th Feb 20249:14 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20242:00 pmRNSResults of Court Meeting and General Meeting
17th Jan 20241:31 pmRNSHolding(s) in Company
17th Jan 20249:42 amRNSForm 8.3 - Sopheon plc
16th Jan 20245:45 pmRNSPublication of Scheme Document
15th Jan 202410:53 amRNSForm 8.3 - Sopheon plc
15th Jan 20248:13 amRNSForm 8.3 - SOPHEON PLC
12th Jan 20243:22 pmRNSForm 8.3 - Sopheon PLC
11th Jan 20248:50 amRNSSatisfaction of NSIA Condition
11th Jan 20248:49 amRNSForm 8.3 - SOPHEON PLC
10th Jan 20249:13 amRNSForm 8.3 - SOPHEON PLC
9th Jan 202412:35 pmRNSForm 8.3 - Sopheon plc
9th Jan 20248:48 amRNSForm 8.3 - SOPHEON PLC
8th Jan 202412:22 pmRNSIssue of Equity
8th Jan 20248:31 amRNSForm 8.3 - SOPHEON PLC
4th Jan 20249:45 amRNSForm 8.3 - SOPHEON PLC
2nd Jan 20245:18 pmRNSForm 8.3 - Sopheon Plc
2nd Jan 20249:07 amRNSForm 8.3 - SOPHEON PLC
22nd Dec 20231:00 pmRNSRecommended Cash Offer
15th Dec 20238:39 amRNSForm 8.5 (EPT/NON-RI)
13th Dec 20238:32 amRNSForm 8.5 (EPT/NON-RI)
12th Dec 202310:55 amRNSForm 8.5 (EPT/NON-RI)
11th Dec 20238:37 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 202310:41 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20238:36 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 20239:16 amRNSForm 8.5 (EPT/NON-RI)
4th Dec 20236:18 pmRNSRule 2.9 Announcement
4th Dec 202312:30 pmRNSIssue of Equity
28th Nov 20237:00 amRNSOffer update - extension to PUSU Deadline
17th Nov 202311:39 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 20239:30 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20232:59 pmRNSForm 8.3 - SOPHEON PLC
10th Nov 202311:40 amRNSForm 8.5 (EPT/NON-RI)
10th Nov 202311:09 amRNSForm 8.3 - Rivomore Limited - Sopheon plc - Amend
9th Nov 20239:15 amRNSForm 8.5 (EPT/NON-RI)
8th Nov 202312:57 pmRNSForm 8.3 - Sopheon plc
8th Nov 202310:25 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
8th Nov 20237:00 amRNSForm 8 (OPD) Sopheon plc
7th Nov 202311:24 amRNSForm 8.5 (EPT/NON-RI)
6th Nov 20231:03 pmRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.